Skip to main content
Solid Tumor Head and Neck Cancer

Head and Neck Cancer

Robotic surgery for head and neck tumors

What are the current applications of robotic surgery in the treatment of head and neck tumors? And how are recent advances expanding the indications to difficult-to-access regions?

Editor's Choice

Progress in immunotherapy for head and neck cancer

Surgery, radiotherapy, and chemotherapy are the primary treatments for advanced head and neck cancer, but checkpoint inhibition has recently shown promise. Delve into the efficacy and safety data for the key agents.

Management of dysphagia in head and neck cancer

Open Access Head and Neck Cancer Review

Speech and language therapists play a key role in the assessment and management of dysphagia following head and neck cancer radiotherapy. What are the current therapeutic approaches and the areas of unmet need?

Stroke prevention measures warranted for head and neck cancer survivors

15-02-2024 Head and Neck Cancer News

People with a history of head and neck cancer have an increased risk for stroke, highlighting the need for early screening and intervention.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare

Case Studies

An aggressive presentation of secretory carcinoma

Open Access Salivary Gland Cancer Case Study

Secretory carcinoma is generally considered a slow-growing, low-grade malignant tumor, but this report describes a patient with high-grade features who presented with a soft-tissue neck mass.

Breast metastases in a male patient with nasopharyngeal carcinoma

Open Access Nasopharyngeal Cancer Case Study

Nasopharyngeal carcinoma is known for its high potential to metastasize, but breast metastasis is rare. The authors describe the first case of synchronous breast metastases in a male patient.

Carcinosarcoma of the parotid gland

Open Access Salivary Gland Cancer Case Study

Carcinosarcomas or malignant mixed tumors of the salivary gland are extremely rare. This report describes the first case of adenoid cystic carcinoma as the carcinomatous component with chondrosarcoma.

Case-Based Insights: Oncology and Hematology (Link opens in a new window)

Refresh your knowledge in Oncology and Hematology: 

  • 45 clinical cases across different topics with relevant clinical images
  • Written by renowned experts 
  • Knowledge-check questions with answers
Try the first set of cases now

Current Reviews

Current Status of Partial Laryngeal Surgery for Advanced Laryngeal Cancer: When and Why?

Open Access Laryngeal Cancer REVIEW

The surgical landscape for advanced laryngeal cancer (LC) has undergone significant transformations since the first total laryngectomy, carried out in 1873, marking over 150 years of evolution toward strategies aiming to the preservation of the …

Metastatic cutaneous squamous cell carcinoma accounts for nearly all squamous cell carcinomas of the parotid gland

Open Access Salivary Gland Cancer REVIEW AND PERSPECTIVES

Primary squamous cell carcinoma of the parotid gland (pSCCP) has long been recognized as a separate entity and is included in the WHO classifications of salivary gland tumors. However, it is widely accepted among head and neck pathologists that …

The impact of margins in laryngeal cancer patients treated with transoral laser microsurgery: a systematic review and meta-analysis

Laryngeal Cancer Review Article

The combined effect of the increased risk of head and neck cancer with advancing age, along with the improvement in life expectancy results in a marked rise in the prevalence of laryngeal squamous cell carcinoma (LSCC) [ 1 ]. Nowadays, early-stage …

Molecular pathology in diagnosis and prognostication of head and neck tumors

Open Access Head and Neck Cancer REVIEW AND PERSPECTIVES

Classification of head and neck tumors has evolved in recent decades including a widespread application of molecular testing in tumors of the salivary glands, sinonasal tract, oropharynx, nasopharynx, and soft tissue. Availability of new molecular …

Webinar | 16-05-2023 | 17:30 (CEST)

Keynote webinar | Spotlight on cardio-oncology

An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.

Prof. Rudolf de Boer
Prof. Lorenz Lehmann
Dr. Teresa Lopéz Fernández

CME & eLearning


Take on interactive case studies with a focus on hematology. Each case has been prepared by renowned experts in the field and features knowledge-check questions with answers to help keep you and your practice up to date.

Developed by: Springer Medizin

Further Reading

DIAPH2 gene polymorphisms and laryngeal cancer risk in men

Open Access Laryngeal Cancer Original Research

Laryngeal squamous cell carcinoma (LSCC) is one of the most common malignancies of the head and neck. It is a significant clinical problem because of its high incidence and the lack of effective treatment. Due to higher rates of tobacco and …

Stapler versus conventional pharyngeal repair after total laryngectomy: a randomized clinical trial

Open Access Laryngectomy Laryngology

Pharyngocutaneous fistula (PCF) is the commonest complication after total laryngectomy [ 1 ]. It develops as a result of leakage of saliva through the pharyngeal repair line [ 2 , 3 ]. PCF contributes to increased morbidity following laryngectomy …

An automated approach for real-time informative frames classification in laryngeal endoscopy using deep learning

Open Access Laryngoscopy Laryngology

High-definition videoendoscopy and laryngoscopy are nowadays the cornerstones of laryngeal examination. The use of Narrow Band Imaging (NBI) optical modality, as opposed to standard White Light (WL) endoscopy, has been demonstrated to offer …

Citalopram, an antipsychotic agent, induces G1/G0 phase cell cycle arrest and promotes apoptosis in human laryngeal carcinoma HEP-2 cells

Open Access Citalopram Original Paper

Human laryngeal squamous carcinoma (LSCC) is a common malignant tumor in the head and neck. Despite the recently developed therapies for the treatment of LSCC, patients’ overall survival rate still did not enhance remarkably; this highlights the …